On Monday, Immunic Inc (NASDAQ: IMUX) was -3.91% drop from the session before, before settling in for the closing price of $0.98. A 52-week range for IMUX has been $0.56 – $1.73.
A company in the Healthcare sector has jumped its sales by 26.01% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 30.00%. With a float of $95.57 million, this company’s outstanding shares have now reached $98.65 million.
Immunic Inc (IMUX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Immunic Inc stocks. The insider ownership of Immunic Inc is 3.12%, while institutional ownership is 69.63%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.24 earnings per share (EPS) during the time that was less than consensus figure (set at -0.22) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.97% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
You can see what Immunic Inc (IMUX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.97, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.79 million. That was better than the volume of 1.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 44.01%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 61.29%, which indicates a significant increase from 43.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0736 in the past 14 days, which was higher than the 0.0688 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8914, while its 200-day Moving Average is $0.9617. However, in the short run, Immunic Inc’s stock first resistance to watch stands at $0.9830. Second resistance stands at $1.0260. The third major resistance level sits at $1.0543. If the price goes on to break the first support level at $0.9117, it is likely to go to the next support level at $0.8834. Assuming the price breaks the second support level, the third support level stands at $0.8404.
Immunic Inc (NASDAQ: IMUX) Key Stats
There are 98,651K outstanding shares of the company, which has a market capitalization of 92.73 million. As of now, sales total 0 K while income totals -100,510 K. Its latest quarter income was 0 K while its last quarter net income were -26,820 K.
